A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer’s disease

被引：0
|
作者：
Shahin Akhondzadeh
Mehdi Shafiee Sabet
Mohammad Hossein Harirchian
Mansoreh Togha
Hamed Cheraghmakani
Soodeh Razeghi
Seyyed Shamssedin Hejazi
Mohammad Hossein Yousefi
Roozbeh Alimardani
Amirhossein Jamshidi
Shams-Ali Rezazadeh
Aboulghasem Yousefi
Farhad Zare
Atbin Moradi
Ardalan Vossoughi
机构：
[1] Tehran University of Medical Sciences,Psychiatric Research Center, Roozbeh Psychiatric Hospital
[2] Institute of Medicinal Plants (ACECR),Department of Neurology
[3] Tehran University of Medical Sciences,Department of Neurology
[4] Qom University of Medical Sciences,Office for Herbal Drugs
[5] Ministry of Health and Medical Education,undefined
来源：
Psychopharmacology | 2010年 / 207卷
关键词：
Cholinesterase inhibitors; Clinical trial; Dementia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：637 / 643
页数：6
相关论文
共 50 条
  • [31] Memantine treatment in mild to moderate Alzheimer disease: A 24-week randomized, controlled trial
    Peskind, Elaine R.
    Potkin, Steven G.
    Pomara, Nunzio
    Ott, Brian R.
    Graham, Stephen M.
    Olin, Jason T.
    McDonald, Scott
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2006, 14 (08): : 704 - 715
  • [32] Normobaric oxygen treatment for mild-to-moderate depression: a randomized, double-blind, proof-of-concept trial
    Yehudit Bloch
    R. H. Belmaker
    Pesach Shvartzman
    Pnina Romem
    Arkady Bolotin
    Yuly Bersudsky
    Abed N. Azab
    [J]. Scientific Reports, 11
  • [33] Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression:: a double-blind, randomized pilot trial
    Noorbala, AA
    Akhondzadeh, S
    Tahmacebi-Pour, N
    Jamshidi, AH
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2005, 97 (02) : 281 - 284
  • [34] Normobaric oxygen treatment for mild-to-moderate depression: a randomized, double-blind, proof-of-concept trial
    Bloch, Yehudit
    Belmaker, R. H.
    Shvartzman, Pesach
    Romem, Pnina
    Bolotin, Arkady
    Bersudsky, Yuly
    Azab, Abed N.
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [35] Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: A multicenter, double-blind, randomized, placebo-controlled trial
    Moreno, MD
    [J]. CLINICAL THERAPEUTICS, 2003, 25 (01) : 178 - 193
  • [36] Possible effects of Saffron (Crocus sativus) in the treatment of erectile dysfunction: A randomized, double-blind, placebo-controlled trial
    Najafabadi, Borna Tadayon
    Farsinejad, Maryam
    Shokraee, Kamyar
    Momtazmanesh, Sara
    Violette, Philippe Denis
    Esalatmanesh, Sophia
    Kashani, Ladan
    Jafarinia, Morteza
    Akhondzadeh, Shahin
    [J]. JOURNAL OF HERBAL MEDICINE, 2022, 32
  • [37] Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease:: a double blind, randomized and placebo-controlled trial
    Akhondzadeh, S
    Noroozian, M
    Mohammadi, M
    Ohadinia, S
    Jamshidi, AH
    Khani, M
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2003, 28 (01) : 53 - 59
  • [38] Treatment with Cerebrolysin, donepezil and a combination therapy in mild to moderate Alzheimer's disease: a double-blind clinical trial
    Alvarez, A.
    Sampedro, C.
    Couceiro, V.
    Cacabelos, R.
    Garcia-Fantini, M.
    Aleixandre, M.
    Linares, C.
    Granizo, E.
    Doppler, E.
    Novak, P.
    Moessler, H.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 342 - 342
  • [39] Efficacy and safety of a transdermal donepezil patch in patients with mild-to-moderate Alzheimer's disease: A 24-week, randomized, multicenter, double-blind, parallel group, non-inferiority study
    Nakamura, Yu
    Kim, Rei
    Nishiyama, Kenichi
    Kikuchi, Takashi
    Ishikawa, Ichiro
    Aoki, Hiroshi
    [J]. GERIATRICS & GERONTOLOGY INTERNATIONAL, 2023, 23 (04) : 275 - 281
  • [40] Randomized double-blind placebo-controlled multicenter trial of Yokukansan for neuropsychiatric symptoms in Alzheimer's disease
    Furukawa, Katsutoshi
    Tomita, Naoki
    Uematsu, Daisuke
    Okahara, Kazunori
    Shimada, Hiroyuki
    Ikeda, Masaki
    Matsui, Toshifumi
    Kozaki, Koichi
    Fujii, Masahiko
    Ogawa, Tatsuji
    Umegaki, Hiroyuki
    Urakami, Katsuya
    Nomura, Hiroshi
    Kobayashi, Naoto
    Nakanishi, Aki
    Washimi, Yukihiro
    Yonezawa, Hisashi
    Takahashi, Satoshi
    Kubota, Masaharu
    Wakutani, Yosuke
    Ito, Daisuke
    Sasaki, Takahiro
    Matsubara, Etsuro
    Une, Kaori
    Ishiki, Aiko
    Yahagi, Yukie
    Shoji, Mikio
    Sato, Hiroyasu
    Terayama, Yasuo
    Kuzuya, Masafumi
    Araki, Nobuo
    Kodama, Manabu
    Yamaguchi, Takuhiro
    Arai, Hiroyuki
    [J]. GERIATRICS & GERONTOLOGY INTERNATIONAL, 2017, 17 (02) : 211 - 218
12345